CAS 1550053-02-5

Formel: C15H14FN3O2

InChl: InChI=1S/C15H14FN3O2/c1-9(20)18-12-5-2-10(3-6-12)15(21)19-14-7-4-11(16)8-13(14)17/h2-8H,17H2,1H3,(H,18,20)(H,19,21)

InChI Key: RRJDFENBXIEAPD-UHFFFAOYSA-N

SMILES: CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)F)N

4-Acetamido-N-(2-Amino-4-Fluorophenyl) Benzamide

CAS: 1550053-02-5

4-Acetamido-N-(2-Amino-4-Fluorophenyl) Benzamide

Formel: C₁₅H₁₄FN₃O₂

Reinheit: 98%

Molekulargewicht: 287.29

Ref: 54-PC108384

BRD3308

CAS: 1550053-02-5

BRD3308

Formel: C₁₅H₁₄FN₃O₂

Reinheit: ≥95%

Molekulargewicht: 287.29

Ref: 54-BUP04923

4-Acetamido-N-(2-amino-4-fluorophenyl)benzamide

CAS: 1550053-02-5

Formel: C₁₅H₁₄FN₃O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 287.2890

Ref: IN-DA01KKI4

BRD3308

CAS: 1550053-02-5

BRD3308 is a highly selective inhibitor of HDAC3(IC50 of 54 nM), attenuating PE-mediated phosphorylation of ERK but not JNK.

Formel: C₁₅H₁₄FN₃O₂

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 287.289

Ref: TM-T8233

BRD 3308

CAS: 1550053-02-5

Inhibitor of histone deacetylase 3 (HDAC3) with IC50 in nanomolar range. BRD 9908 was shown to preserve the insulin-secreting pancreatic cells in nonobese diabetic mice. BRD 3308 supressed infiltration of mononuclear cells and prevented β-cell death in vivo as well as increased basal insulin secretion in vitro. Studies on HIV infection models showed that HDAC3 inhibition by BRD 3308 disrupts the HIV latency by increasing the gene expression from HIV promoter.

Formel: C₁₅H₁₄FN₃O₂

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 287.29 g/mol

Ref: 3D-BB168411

BRD3308

CAS: 1550053-02-5

4-Acetamido-N-(2-amino-4-fluorophenyl)benzamide

Formel: C₁₅H₁₄FN₃O₂

Reinheit: 98%

Molekulargewicht: 287.29

Ref: IN-DG768265